506919 Stock Overview
An integrated pharmaceutical company, manufactures and markets formulations in India. More details
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 0/6 |
| Past Performance | 2/6 |
| Financial Health | 5/6 |
| Dividends | 0/6 |
Community vs My Fair Value
Create NarrativeSelect a narrative for quick price alerts from the community, or create your own.
Makers Laboratories Limited Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | ₹130.30 |
| 52 Week High | ₹230.00 |
| 52 Week Low | ₹114.00 |
| Beta | 1.29 |
| 1 Month Change | -2.76% |
| 3 Month Change | -23.33% |
| 1 Year Change | -5.31% |
| 3 Year Change | -18.10% |
| 5 Year Change | 228.63% |
| Change since IPO | 261.94% |
Recent News & Updates
Recent updates
Shareholder Returns
| 506919 | IN Pharmaceuticals | IN Market | |
|---|---|---|---|
| 7D | -7.6% | -2.4% | -1.6% |
| 1Y | -5.3% | 12.4% | 1.7% |
Return vs Industry: 506919 underperformed the Indian Pharmaceuticals industry which returned 13.9% over the past year.
Return vs Market: 506919 underperformed the Indian Market which returned 3.1% over the past year.
Price Volatility
| 506919 volatility | |
|---|---|
| 506919 Average Weekly Movement | 7.7% |
| Pharmaceuticals Industry Average Movement | 7.3% |
| Market Average Movement | 7.2% |
| 10% most volatile stocks in IN Market | 9.9% |
| 10% least volatile stocks in IN Market | 4.8% |
Stable Share Price: 506919 has not had significant price volatility in the past 3 months compared to the Indian market.
Volatility Over Time: 506919's weekly volatility (8%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1984 | 121 | Saahil Parikh | www.makerslabs.com |
Makers Laboratories Limited, an integrated pharmaceutical company, manufactures and markets formulations in India. The company offers general health therapeutic products, such as acid regulatory, anthelmintic, anti-allergic, anti-asthmatic, anti-biotic, anti-diabetics, anti-diarrhoeals, anti-emetics and anti-nauseants, anti-fungal, anti-hypertensive, anti–inflammatory, analgesic, anti-spasmodic, anti-malarial, and anti-thyroid. It also provides cough and cold control, digestives, neurotonics, nutritional supplements, topical anti-biotic/anti-microbial, and other specialties drugs.
Makers Laboratories Limited Fundamentals Summary
| 506919 fundamental statistics | |
|---|---|
| Market cap | ₹768.82m |
| Earnings (TTM) | ₹62.50m |
| Revenue (TTM) | ₹1.15b |
12.3x
P/E Ratio0.7x
P/S RatioIs 506919 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 506919 income statement (TTM) | |
|---|---|
| Revenue | ₹1.15b |
| Cost of Revenue | ₹578.94m |
| Gross Profit | ₹567.64m |
| Other Expenses | ₹505.14m |
| Earnings | ₹62.50m |
Last Reported Earnings
Dec 31, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | 10.59 |
| Gross Margin | 49.51% |
| Net Profit Margin | 5.45% |
| Debt/Equity Ratio | 6.9% |
How did 506919 perform over the long term?
See historical performance and comparisonCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2025/05/09 14:42 |
| End of Day Share Price | 2025/05/09 00:00 |
| Earnings | 2024/12/31 |
| Annual Earnings | 2024/03/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
Makers Laboratories Limited is covered by 1 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Anil Burra | FirstCall Research |